# Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

> **NCT01344681** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 153 (actual)

## Conditions studied

- Febrile Neutropenia
- Hematological Diseases

## Interventions

- **DRUG:** Micafungin sodium
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT01344681
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2014-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01344681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01344681, "Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01344681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*